Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion

Journal of Cellular Physiology

Volumn 229, Issue 9, 2014, Pages 1202-1211

  Chen, Hsi Hsien ^a,b   Lai, Pei Fang ^c   Lan, Yi Fan ^d   Cheng, Ching Feng ^c,e   Zhong, Wen Bing ^b   Lin, Yuh Feng ^f   Chen, Tzen Wen ^a,b   Lin, Heng ^b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EXOSOME; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; INFLAMMATION; KIDNEY EPITHELIUM; KIDNEY ISCHEMIA; KNOCKOUT MOUSE; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; RENAL ISCHEMIA REPERFUSION; REPERFUSION INJURY; WILD TYPE;

ACTIVATING TRANSCRIPTION FACTOR 3; ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BINDING SITES; CELL LINE; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPITHELIAL CELLS; EXOSOMES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RATS; REPERFUSION INJURY; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84901236313     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24554     Document Type: Article

References (38)

1. Al-Nedawi K, Szemraj J, Cierniewski CS. 2005. Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol 25:1744-1749.
2. Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. 2012. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int 82:1024-1032.
3. Bonventre JV, Zuk A. 2004. Ischemic acute renal failure: An inflammatory disease? Kidney Int 66:480-485.
4. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G. 2009. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067.
5. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. 2005. Exosomal-like vesicles are present in human blood plasma. Int Immunol 17:879-887.
6. Cai Y, Zhang C, Nawa T, Aso T, Tanaka M, Oshiro S, Ichijo H, Kitajima S. 2000. Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: Activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood 96:2140-2148.
7. Chen HH, Chen TW, Lin H. 2009. Prostacyclin-induced peroxisome proliferator- activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 297:1109-1118.
8. Cheng CF, Lin H. 2011. Acute kidney injury and the potential for ATF3-regulated epigenetic therapy. Toxicol Mech Methods 21:362-366.
9. Colotta F, Sironi M, Borrè A. 1992. Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells. Cytokine 4:24-28.
10. Conde-Vancells J, Rodriguez-Suarez E, Gonzalez E, Berisa A, Gil D, Embade N, Valle M, Luka Z, Elortza F, Wagner C, Lu SC, Mato JM, Falcon-Perez M. 2010. Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl 4:416-425.
11. Gersch MS, Mu W, Cirillo P, Reungjui S, Zhang L, Roncal C, Sautin YY, Johnson RJ, Nakagawa T. 2007. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 293:1256-1261.
12. Glushakova O, Kosugi T, Roncal C, Mu W, Heinig M, Cirillo P, Sánchez- Lozada LG, Johnson RJ, Nakagawa T. 2008. Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol 19:1712-1720.
13. Gold ES, Ramsey SA, Sartain MJ, Selinummi J, Podolsky I, Rodriguez DJ, Moritz RL, Aderem A. 2012. ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J Exp Med 9:807-817.
14. Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA. 2009. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 20:363-379.
15. Hai T, Hartman MG. 2001. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: Activating transcription factor proteins and homeostasis. Gene 273:1-11.
16. Hodge DL, Reynolds D, Cerbán FM, Correa SG, Baez NS, Young HA. 2012. Rodriguez-Galan MC. MCP-1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes. Eur J Immunol 42:2644-2654.
17. Hoetzenecker W, Echtenacher B, Guenova E, Hoetzenecker K, Woelbing F, Brück J, Teske A, Valtcheva N, Fuchs K, Kneilling M, Park JH, Kim KH, Kim KW, Hoffmann P, Krenn C, Hai T, Ghoreschi K, Biedermann T, Röcken M. 2011. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med 18:128-134.
18. Hood JL, San RS, Wickline SA. 2011. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 71:3792-3801.
19. Hu G, Gong AY, Roth AL, Huang BQ, Ward HD, Zhu G, Larusso NF, Hanson ND, Chen XM. 2013. Release of luminal exosomes contributes to TLR4- mediated epithelial antimicrobial defense. PLoS Pathog 9:e1003261.
20. Kaszubska W, Hooft van Huijsduijnen R, Ghersa P, DeRaemy-Schenk AM, Chen BP, Hai T, DeLamarter JF, Whelan J. 1993. Cyclic AMP- independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol Cell Biol 13:7180-7190.
21. Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringnér M, Mörgelin M, Bourseau-Guilmain E, Bengzon J, Belting M. 2013. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci USA 110:7312-7317.
22. Kunin M, Holtzman EJ, Melnikov S, Dinour D. 2012. Urinary organic anion transporter protein profiles in AKI. Nephrol Dial Transplant 27:1387-1395.
23. Li D, Yin X, Zmuda EJ, Wolford CC, Dong X, White MF, Hai T. 2008. The repression of IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell apoptosis. Diabetes 57:635-644.
24. Li HF, Cheng CF, Liao WJ, Lin H, Yang RB. 2010. ATF3-mediated epigenetic regulation protects against acute kidney injury. J Am Soc Nephrol 21:1003-1013.
25. Li Y, Zhang Y, Qiu F, Qiu Z. 2011. Proteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC. Electrophoresis 32:1976-1983.
26. Liang G, Wolfgang CD, Chen BP, Chen TH, Hai T. 1996. ATF3 gene. Genomic organization, promoter, and regulation. J Biol Chem 271:1695-1701.
27. Miotto D, Boschetto P, Bononi I, Milani G, Legorini C, Cavallesco G, Lo Cascio N, Zeni E, Fabbri LM, Mapp CE. 2007. CC ligand 2 levels are increased in LPS-stimulated peripheral monocytes of patients with non-small cell lung cancer. Respir Med 101:1738-1743.
28. Munshi R, Johnson A, Siew ED, Ikizler TA, Ware LB, Wurfel MM, Himmelfarb J, Zager RA. 2011. MCP-1 gene activation marks acute kidney injury. J Am Soc Nephrol 22:165-175.
29. Pisitkun T, Shen RF, Knepper MA. 2004. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 101:13368-13373.
30. Rani S, O'Brien K, Kelleher FC, Corcoran C, Germano S, Radomski MW, Crown J, O'Driscoll L. 2011. Isolation of exosomes for subsequent mRNA, MicroRNA, and protein profiling. Methods Mol Biol 84:181-195.
31. Street JM, Birkhoff W, Menzies RI, Webb DJ, Bailey MA, Dear JW. 2011. Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J Physiol 5:6119-6127.
32. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR. 1999. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103:73-80.
33. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659.
34. van Balkom BW, de Jong OG, Smits M, Brummelman J, den Ouden K, de Bree PM, van Eijndhoven MA, Pegtel DM, Stoorvogel W, Würdinger T, Verhaar MC. 2013. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood 21:3997-4006.
35. Weiss JM, Cuff CA, Berman JW. 1999. TGF-beta downmodulates cytokine-induced monocyte chemoattractant protein (MCP)-1 expression in human endothelial cells. A putative role for TGF-beta in the modulation of TNF receptor expression. Endothelium 6:291-302.
36. Yoshida T, Sugiura H, Mitobe M, Tsuchiya K, Shirota S, Nishimura S, Shiohira S, Ito H, Nobori K, Gullans SR, Akiba T, Nitta K. 2008. ATF3 protects against renal ischemia- reperfusion injury. J Am Soc Nephrol 19:217-224.
37. Zager RA, Johnson AC. 2009. Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol 296:1032-1041.
38. Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, Berger A, Leelahavanichkul A, Doi K, Chawla LS, Illei GG, Kopp JB, Balow JE, Austin III, HA, Yuen PS, Star RA. 2008. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 74:613-621.